Pascal Waucquez
Vice President, Global Center of Excellence
Stiefel, a GSK company

Pascal Waucquez is vice president of the Global Center of Excellence (CoE) for the prescription business of Stiefel, a GSK company. Stiefel, acquired by GlaxoSmithKline in July 2009, is a specialty business unit within GSK. As vice president of the CoE Pharmaceuticals, Pascal is responsible for setting the global marketing strategies for the dermatology prescription business. His team looks after both the currently marketed as well as the pipeline assets. Pascal and his team work closely with global, R&D, and business development colleagues to ensure the strategy meets the needs of the patients, doctors and payers across the world and is implemented globally.

Prior to GSK’s acquisition of Stiefel, Pascal served in various positions at Stiefel including Managing Director of Stiefel in the UK, General Manager of Stiefel in Italy and European Marketing Director. His accomplishments in these roles included leading the creation of the European marketing team; reorganizing of the UK commercial team to aligned with the customers’ needs; securing registration and pricing of Duac® in Italy; and leading the Italian team to achieve market leadership with Duac® within two months of launch.

Before joining Stiefel in 2004, Pascal worked for Johnson and Johnson and Eli Lilly, holding various sales and marketing positions, and in manufacturing in UCB Pharma. In addition, Pascal has held P&L responsibility both in the UK and in Italy.

Pascal holds a master of science in Chemical Engineering from the Universite Catholique de Louvain (UCL) in Belgium and a MBA from Insead in France.

«Back to Stiefel Leadership Team